Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 6/2015

01-06-2015 | Colorectal Cancer

Radical Surgery with Total Mesorectal Excision in Patients with T1 Rectal Cancer

Authors: Yakup Kulu, MD, Beat P. Müller-Stich, MD, Thomas Bruckner, PhD, Tobias Gehrig, MD, Markus W. Büchler, MD, Frank Bergmann, MD, Alexis Ulrich, MD

Published in: Annals of Surgical Oncology | Issue 6/2015

Login to get access

Abstract

Background

Radical resection with total mesorectal excision (TME) is the accepted standard of care for most rectal cancers. However, T1 rectal cancers may be at low risk for metastases and are therefore treatable with local resection. The aim of our study was to investigate whether the identification of these patients is possible through existing selection criteria.

Methods

Between 2001 and 2012, radical resection with TME was performed in 68 patients with a histologically confirmed T1 adenocarcinoma of the rectum. Each patient was staged preoperatively as lymph node negative. Patients at low risk to metastasize were defined as proposed by Hermanek and Gall (Int J Colorectal Dis 1(2):79–84, 1986), Kikuchi et al. (Dis Colon Rectum 38(12):1286–1295, 1995) and Hase et al. (Dis Colon Rectum 38(1):19–26, 1995) Postoperative morbidity, mortality, and oncological outcome were analyzed.

Results

Despite nodal negative staging, 9 of 68 patients (13 %) were node positive. Following the proposal of Hermanek and Gall, Kikuchi et al., and Hase et al., 14 % (5/37), 12 % (3/26), and 16 % (6/38) of patients, respectively, with low-risk tumors had lymph node metastases. In the univariate analysis, none of the investigated parameters could predict lymph node metastases. Following radical resection, none of the patients, regardless of nodal involvement, developed a recurrence.

Conclusions

Preoperative diagnostics regarding lymphatic tumor propagation and histomorphological assessment of tumor samples as predictors of lymph node metastasis are unreliable. Following radical resection with TME, the oncological outcome of node-positive patients with T1 rectal adenocarcinoma is comparable with that of lymph node-negative patients. Considering the lymph node metastases rate, a local excision should always be complemented with additional therapy.
Literature
1.
Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1(8496):1479–82.CrossRefPubMed
2.
Rahbari NN, Ulrich AB, Bruckner T, et al. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure? Ann Surg. 2011;253(3):522–33.CrossRefPubMed
3.
Contin P, Kulu Y, Bruckner T, et al. Comparative analysis of late functional outcome following preoperative radiation therapy or chemoradiotherapy and surgery or surgery alone in rectal cancer. Int J Colorectal Dis. 2014;29(2):165–75.CrossRefPubMed
4.
Khoo CK, Vickery CJ, Forsyth N, Vinall NS, Eyre-Brook IA. A prospective randomized controlled trial of multimodal perioperative management protocol in patients undergoing elective colorectal resection for cancer. Ann Surg. 2007;245(6):867–72.CrossRefPubMedCentralPubMed
5.
Chuwa EW, Seow-Choen F. Outcomes for abdominoperineal resections are not worse than those of anterior resections. Dis Colon Rectum. 2006;49(1):41–9.CrossRefPubMed
6.
Bentrem DJ, Okabe S, Wong WD, et al. T1 adenocarcinoma of the rectum: transanal excision or radical surgery? Ann Surg. 2005;242(4):472–7; discussion 477–9.PubMedCentralPubMed
7.
Bhangu A, Brown G, Nicholls RJ, Wong J, Darzi A, Tekkis P. Survival outcome of local excision versus radical resection of colon or rectal carcinoma: a surveillance, epidemiology, and end results (SEER) population-based study. Ann Surg. 2013;258(4):563–9; discussion 569–71.PubMed
8.
Chang AJ, Nahas CS, Araujo SE, Nahas SC, Marques CF, Kiss DR, et al. Early rectal cancer: local excision or radical surgery? J Surg Educ. 2008;65(1):67–72.CrossRefPubMed
9.
Peng J, Chen W, Sheng W, Xu Y, Cai G, Huang D, et al. Oncological outcome of T1 rectal cancer undergoing standard resection and local excision. Colorectal Dis. 2011;13(2):e14–9.CrossRefPubMed
10.
Tytherleigh MG, Warren BF, Mortensen NJ. Management of early rectal cancer. Br J Surg. 2008;95(4):409–23.CrossRefPubMed
11.
Madbouly KM, Remzi FH, Erkek BA, et al. Recurrence after transanal excision of T1 rectal cancer: should we be concerned? Dis Colon Rectum. 2005;48(4):711-9; discussion 719–21.CrossRefPubMed
12.
You YN, Baxter NN, Stewart A, Nelson H. Is the increasing rate of local excision for stage I rectal cancer in the United States justified?: a nationwide cohort study from the National Cancer Database. Ann Surg. 2007;245(5):726–33.CrossRefPubMedCentralPubMed
13.
14.
Landmann RG, Wong WD, Hoepfl J, et al. Limitations of early rectal cancer nodal staging may explain failure after local excision. Dis Colon Rectum. 2007;50(10):1520–5.CrossRefPubMed
15.
Muthusamy VR, Chang KJ. Optimal methods for staging rectal cancer. Clin Cancer Res. 2007;13(22 Pt 2):6877s–84s.CrossRefPubMed
16.
Hermanek P, Merkel S, Fietkau R, Rodel C, Hohenberger W. Regional lymph node metastasis and locoregional recurrence of rectal carcinoma in the era of TME [corrected] surgery. Implications for treatment decisions. Int J Colorectal Dis. 2010;25(3):359–68.CrossRefPubMed
17.
Kosinski L, Habr-Gama A, Ludwig K, Perez R. Shifting concepts in rectal cancer management: a review of contemporary primary rectal cancer treatment strategies. CA Cancer J Clin. 2012;62(3):173–202.CrossRefPubMed
18.
Park JS, Jang YJ, Choi GS, Park SY, Kim HJ, Kang H, et al. Accuracy of preoperative MRI in predicting pathology stage in rectal cancers: node-for-node matched histopathology validation of MRI features. Dis Colon Rectum. 2014;57(1):32–8.CrossRefPubMed
19.
Hase K, Shatney CH, Mochizuki H, Johnson DL, Tamakuma S, Vierra M, et al. Long-term results of curative resection of “minimally invasive” colorectal cancer. Dis Colon Rectum. 1995;38(1):19–26.CrossRefPubMed
20.
Hermanek P, Gall FP. Early (microinvasive) colorectal carcinoma. Pathology, diagnosis, surgical treatment. Int J Colorectal Dis. 1986;1(2):79–84.CrossRefPubMed
21.
Kikuchi R, Takano M, Takagi K, Fujimoto N, Nozaki R, Fujiyoshi T, et al. Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum. 1995;38(12):1286–95.CrossRefPubMed
22.
Kitajima K, Fujimori T, Fujii S, et al. Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study. J Gastroenterol. 2004;39(6):534–43.CrossRefPubMed
23.
Shimomura T, Ishiguro S, Konishi H, et al. New indication for endoscopic treatment of colorectal carcinoma with submucosal invasion. J Gastroenterol Hepatol. 2004;19(1):48–55.CrossRefPubMed
24.
Hase K, Shatney C, Johnson D, Trollope M, Vierra M. Prognostic value of tumor “budding” in patients with colorectal cancer. Dis Colon Rectum. 1993;36(7):627–35.CrossRefPubMed
25.
Masaki T, Matsuoka H, Sugiyama M, et al. Budding as a useful determinant of the optimal treatment for T1 rectal carcinomas. Hepatogastroenterology. 2003;50(50):388–91.PubMed
26.
Morson BC, Whiteway JE, Jones EA, Macrae FA, Williams CB. Histopathology and prognosis of malignant colorectal polyps treated by endoscopic polypectomy. Gut. 1984;25(5):437–44.CrossRefPubMedCentralPubMed
27.
Wilcox GM, Anderson PB, Colacchio TA. Early invasive carcinoma in colonic polyps. A review of the literature with emphasis on the assessment of the risk of metastasis. Cancer. 1986;57(1):160–71.CrossRefPubMed
28.
Pollack J, Holm T, Cedermark B, Altman D, Holmstrom B, Glimelius B, et al. Late adverse effects of short-course preoperative radiotherapy in rectal cancer. Br J Surg. 2006;93(12):1519–25.CrossRefPubMed
29.
Brodsky JT, Richard GK, Cohen AM, Minsky BD. Variables correlated with the risk of lymph node metastasis in early rectal cancer. Cancer. 1992;69(2):322–6.CrossRefPubMed
30.
Blumberg D, Paty PB, Guillem JG, Picon AI, Minsky BD, Wong WD, et al. All patients with small intramural rectal cancers are at risk for lymph node metastasis. Dis Colon Rectum. 1999;42(7):881–5.CrossRefPubMed
31.
Goldstein NS, Hart J. Histologic features associated with lymph node metastasis in stage T1 and superficial T2 rectal adenocarcinomas in abdominoperineal resection specimens. Identifying a subset of patients for whom treatment with adjuvant therapy or completion abdominoperineal resection should be considered after local excision. Am J Clin Pathol. 1999;111(1):51–8.PubMed
32.
Ptok H, Marusch F, Meyer F, et al. Oncological outcome of local vs radical resection of low-risk pT1 rectal cancer. Arch Surg. 2007;142(7):649–55; discussion 656.CrossRefPubMed
33.
Winde G, Nottberg H, Keller R, Schmid KW, Bunte H. Surgical cure for early rectal carcinomas (T1). Transanal endoscopic microsurgery vs. anterior resection. Dis Colon Rectum. 1996;39(9):969–76.CrossRefPubMed
34.
Palma P, Freudenberg S, Samel S, Post S. Transanal endoscopic microsurgery: indications and results after 100 cases. Colorectal Dis. 2004;6(5):350–5.CrossRefPubMed
35.
Tarantino I, Hetzer FH, Warschkow R, Zund M, Stein HJ, Zerz A. Local excision and endoscopic posterior mesorectal resection versus low anterior resection in T1 rectal cancer. Br J Surg. 2008; 95(3):375–80.CrossRefPubMed
36.
Okabe S, Kanenobu M, Matsumoto A, Murase N, Yabata E, Takemura K, et al. Controversy on therapeutic modality to early colorectal carcinomas from the viewpoint of histopathological features (in Japanese). Nihon Geka Gakkai Zasshi. 1992;93(9):1079–82.PubMed
37.
Kulu Y, Ulrich A, Bruckner T, et al. Validation of the International Study Group of Rectal Cancer definition and severity grading of anastomotic leakage. Surgery. 2013;153(6):753–61.CrossRefPubMed
38.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.CrossRefPubMedCentralPubMed
39.
40.
Rahbari NN, Weitz J, Hohenberger W, et al. Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery. 2010;147(3):339–51.CrossRefPubMed
41.
Chok KS, Law WL. Prognostic factors affecting survival and recurrence of patients with pT1 and pT2 colorectal cancer. World J Surg. 2007;31(7):1485–90.CrossRefPubMed
42.
Sitzler PJ, Seow-Choen F, Ho YH, Leong AP. Lymph node involvement and tumor depth in rectal cancers: an analysis of 805 patients. Dis Colon Rectum. 1997;40(12):1472–6.CrossRefPubMed
43.
Haggitt RC, Glotzbach RE, Soffer EE, Wruble LD. Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology. 1985;89(2):328–36.PubMed
44.
Sticca RP, Rodriguez-Bigas M, Penetrante RB, Petrelli NJ. Curative resection for stage I rectal cancer: natural history, prognostic factors, and recurrence patterns. Cancer Invest. 1996;14(5):491–7.CrossRefPubMed
45.
Pollard CW, Nivatvongs S, Rojanasakul A, Reiman HM, Dozois RR. The fate of patients following polypectomy alone for polyps containing invasive carcinoma. Dis Colon Rectum. 1992;35(10):933–7.CrossRefPubMed
46.
Doornebosch PG, Ferenschild FT, de Wilt JH, Dawson I, Tetteroo GW, de Graaf EJ. Treatment of recurrence after transanal endoscopic microsurgery (TEM) for T1 rectal cancer. Dis Colon Rectum. 2010;53(9):1234–9.CrossRefPubMed
47.
Weiser MR, Landmann RG, Wong WD, et al. Surgical salvage of recurrent rectal cancer after transanal excision. Dis Colon Rectum. 2005;48(6):1169–75.CrossRefPubMed
48.
Wagman RT, Minsky BD. Conservative management of rectal cancer with local excision and adjuvant therapy. Oncology (Williston Park). 2001;15(4):513–9, 524; discussion 524–8.
49.
Lamont JP, McCarty TM, Digan RD, Jacobson R, Tulanon P, Lichliter WE. Should locally excised T1 rectal cancer receive adjuvant chemoradiation? Am J Surg. 2000;180(6):402–5; discussion 405–6.CrossRefPubMed
50.
Stitzenberg KB, Sanoff HK, Penn DC, Meyers MO, Tepper JE. Practice patterns and long-term survival for early-stage rectal cancer. J Clin Oncol. 2013;31(34):4276–82.CrossRefPubMedCentralPubMed
51.
Benson R, Wong CS, Cummings BJ, Brierley J, Catton P, Ringash J, et al. Local excision and postoperative radiotherapy for distal rectal cancer. Int J Radiat Oncol Biol Phys. 2001;50(5):1309–16.CrossRefPubMed
52.
Guerrieri M, Feliciotti F, Baldarelli M, Zenobi P, De Sanctis A, Lezoche G, et al. Sphincter-saving surgery in patients with rectal cancer treated by radiotherapy and transanal endoscopic microsurgery: 10 years’ experience. Dig Liver Dis. 2003;35(12):876–80.CrossRefPubMed
53.
Lezoche E, Guerrieri M, Paganini AM, Baldarelli M, De Sanctis A, Lezoche G. Long-term results in patients with T2–3 N0 distal rectal cancer undergoing radiotherapy before transanal endoscopic microsurgery. Br J Surg. 2005;92(12):1546–52.CrossRefPubMed
54.
Caricato M, Borzomati D, Ausania F, et al. Complementary use of local excision and transanal endoscopic microsurgery for rectal cancer after neoadjuvant chemoradiation. Surg Endosc. 2006;20(8):1203–7.CrossRefPubMed
55.
Marks JH, Valsdottir EB, DeNittis A, et al. Transanal endoscopic microsurgery for the treatment of rectal cancer: comparison of wound complication rates with and without neoadjuvant radiation therapy. Surg Endosc. 2009;23(5):1081–7.CrossRefPubMed
56.
Kulu Y, Buchler MW, Ulrich A. [Radiotherapy-associated morbidity and mortality in rectal surgery [in German]. Chirurg. 2013;84(11):951–6.CrossRefPubMed
57.
Kulu Y, Ulrich A, Buchler MW. Resectable rectal cancer: which patient does not need preoperative radiotherapy? Dig Dis. 2012;30 Suppl 2:118–25.CrossRefPubMed
58.
Garcia-Aguilar J, Shi Q, Thomas CR Jr, et al. A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial. Ann Surg Oncol. 2012;19(2):384–91.CrossRefPubMed
59.
Zerz A, Beck J, Szinicz G. [Dorso-posterior extraperitoneal pelviscopy (DEP). From experiment to initial clinical application (in German). Chirurg. 1999;70(3):294–7.CrossRefPubMed
60.
Zerz A, Muller-Stich BP, Beck J, Linke GR, Tarantino I, Lange J. Endoscopic posterior mesorectal resection after transanal local excision of T1 carcinomas of the lower third of the rectum. Dis Colon Rectum. 2006;49(6):919–24.CrossRefPubMed
61.
Koninger J, Muller-Stich BP, Autschbach F, Kienle P, Weitz J, Buchler MW, et al. Endoscopic posterior mesorectal resection as an option to combine local treatment of early stage rectal cancer with partial mesorectal lymphadenectomy. Langenbecks Arch Surg. 2007;392(5):567–71.CrossRefPubMed
Metadata
Title
Radical Surgery with Total Mesorectal Excision in Patients with T1 Rectal Cancer
Authors
Yakup Kulu, MD
Beat P. Müller-Stich, MD
Thomas Bruckner, PhD
Tobias Gehrig, MD
Markus W. Büchler, MD
Frank Bergmann, MD
Alexis Ulrich, MD
Publication date
01-06-2015
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 6/2015
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-4179-3

Other articles of this Issue 6/2015

Annals of Surgical Oncology 6/2015 Go to the issue

Hepatobiliary Tumors

Survival Benefit of Liver Transplantation Versus Resection for Hepatocellular Carcinoma: Impact of MELD Score

Gynecologic Oncology

Risk Factors for the Development of Uterine Cancer in Breast Cancer Survivors: An Army of Women Study

Gastrointestinal Oncology

A Nomogram to Predict Overall Survival and Disease-Free Survival After Curative Resection of Gastric Adenocarcinoma

Breast Oncology

Persistent Postmastectomy Pain and Pain-Related Physical and Emotional Functioning With and Without a Continuous Paravertebral Nerve Block: A Prospective 1-Year Follow-Up Assessment of a Randomized, Triple-Masked, Placebo-Controlled Study

Breast Oncology

Breast Cancer Screening at the Breast Examination Center of Harlem

Pancreatic Tumors

Additional Support for Neoadjuvant Therapy in the Management of Pancreatic Cancer